Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review

DSpace/Manakin Repository

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review

Citable link to this page

 

 
Title: Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
Author: Rentz, Dorene M; Parra Rodriguez, Mario A; Amariglio, Rebecca; Stern, Yaakov; Sperling, Reisa; Ferris, Steven

Note: Order does not necessarily reflect citation order of authors.

Citation: Rentz, Dorene M, Mario A Parra Rodriguez, Rebecca Amariglio, Yaakov Stern, Reisa Sperling, and Steven Ferris. 2013. “Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review.” Alzheimer's Research & Therapy 5 (6): 58. doi:10.1186/alzrt222. http://dx.doi.org/10.1186/alzrt222.
Full Text & Related Files:
Abstract: Recently published guidelines suggest that the most opportune time to treat individuals with Alzheimer’s disease is during the preclinical phase of the disease. This is a phase when individuals are defined as clinically normal but exhibit evidence of amyloidosis, neurodegeneration and subtle cognitive/behavioral decline. While our standard cognitive tests are useful for detecting cognitive decline at the stage of mild cognitive impairment, they were not designed for detecting the subtle cognitive variations associated with this biomarker stage of preclinical Alzheimer’s disease. However, neuropsychologists are attempting to meet this challenge by designing newer cognitive measures and questionnaires derived from translational efforts in neuroimaging, cognitive neuroscience and clinical/experimental neuropsychology. This review is a selective summary of several novel, potentially promising, approaches that are being explored for detecting early cognitive evidence of preclinical Alzheimer’s disease in presymptomatic individuals.
Published Version: doi:10.1186/alzrt222
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978443/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:13454840
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters